Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7295281

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
444,127,000 JPY
816,701,000 JPY
365,516,000 JPY
Ordinary profit (loss)
64,211,000 JPY
125,413,000 JPY
30,639,000 JPY
Net assets
1,336,823,000 JPY
1,265,311,000 JPY
1,105,478,000 JPY
Total assets
1,645,596,000 JPY
1,618,582,000 JPY
1,434,394,000 JPY
Basic earnings (loss) per share
7.68
20.05
2.88
Diluted earnings per share
Equity-to-asset ratio
0.812 xbrli:pure
0.782 xbrli:pure
0.771 xbrli:pure
Net cash provided by (used in) operating activities
76,778,000 JPY
133,775,000 JPY
7,081,000 JPY
Net cash provided by (used in) investing activities
-44,161,000 JPY
-24,496,000 JPY
-8,821,000 JPY
Net cash provided by (used in) financing activities
-38,857,000 JPY
991,000 JPY
2,996,000 JPY
Cash and cash equivalents
665,662,000 JPY
674,969,000 JPY
566,074,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.